Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures

Completed · Phase 2

Conditions studied: Epilepsy

In brief

Evaluate the safety and efficacy of intranasal Clonazepam in subjects with epilepsy.

Key facts

Study ID

NCT00594945

Run by

Jazz Pharmaceuticals

People needed

45

Starts

2007-12-01

Expected to finish

2009-06-01

Last updated by the study team

2014-07-01

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of refractory epilepsy
• No Nasal conditions that would preclude the use of intranasal product

You may not qualify if…

• Subject with a clinical significant unstable medical abnormality
• Subject currently or regularly taking Clonazepam

Where it is running

• Clinical Trials. inc. — Little Rock, Arkansas, United States
• Mid-Atlantic Epilepsy & Sleep Center — Bethesda, Maryland, United States
• Columbia Comprehensive Epilepsy Center, Neurological Institute — New York, New York, United States
• Ohio State University — Columbus, Ohio, United States
• Neurological Clinic of Texas, PA — Dallas, Texas, United States
• Tampere University Hospital — Tampere, Finland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.